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Abstract
Peptides or small-size proteins are important substances for medicines, diagno-
sis, and molecular biology research. In organic synthesis, the peptide bonds forma-
tion is performed in an organic solution (liquid-phase peptide synthesis, LPPS), or 
on a resin (solid-phase peptides synthesis, SPPS). LPPS can prepare a high volume 
of peptides, but it is generally required long processes and high cost for peptides 
preparation and is not appropriate for long-chain peptides. SPPS can prepare long-
chain peptides until 40 residues in a short time. However, it is difficult to obtain 
the pure peptides because of no purification of its intermediates. For a solution of 
these problems, Kent et al. reported native chemical ligation (NCL) method for the 
preparation of long-chain peptides. Because peptides with a long chain or difficult 
sequence formed β-sheet structure within a molecule, these peptides have high 
aggregability and low solubility, and their preparation and purification are gener-
ally difficult. Mutter et al. reported ‘pseudoproline’ method for difficult sequence-
containing peptide preparation. We previously reported a series of prodrugs based 
on O-N intramolecular acyl migration. We reported ‘O-isoacylpeptide’ method 
for the preparation of difficult sequence-containing peptides using the prodrug 
strategy based on O-N intramolecular acyl migration.
Keywords: difficult sequence-containing peptide, long-chain peptide, O-N 
intramolecular acyl migration, peptide synthesis, isoacylpeptide
1. Introduction
Peptides or small-size proteins are important substances for medicines, diagnosis, 
and molecular biology research, such as enzyme inhibitors, antagonists/agonists 
against receptors, antigenic peptides for antibody preparation, and peptide probes 
that detect a protein-peptide interaction. There are two general methodologies 
for peptide preparation—organic synthesis and genetic engineered synthesis. In 
organic synthesis, the peptide bonds formation is performed in an organic solution 
(liquid-phase peptide synthesis, LPPS), or on a resin (solid-phase peptides synthesis, 
SPPS). LPPS can prepare a high volume of peptides, but it is generally required long 
processes and high cost containing labor cost and is not appropriate for long-chain 
peptides. SPPS can prepare long-chain peptides until 40 residues in a short time. 
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However, it is difficult to obtain the pure peptides because of no purification of their 
intermediates. For a solution of these problem, Kent et al. reported native chemi-
cal ligation (NCL) method for the preparation of long-chain peptides as shown in 
Figure 1A [1–3]. In NCL reaction, a peptide possessing thioester at the C-terminus 
and a peptide possessing Cys residue at the N-terminus are prepared by SPPS. Next, 
both peptides are condensed by nucleophilic attack of thiol group at the N-terminus 
Cys residue in an aqueous solution, and then the condensed peptide with a thioester 
bond is spontaneously transformed into the peptide in which both peptides are 
connected with an amide bond. Although NCL allowed to preparing the long-chain 
peptides, this method is only available for the preparation of peptides with one or 
more Cys residues. Yan and Dawson [4] reported a modified NCL method for prepa-
ration of the peptides with one or more Ala residues (Figure 1B, R1 = R2 = ▬H). In 
this reaction, the Cys-containing peptides that were obtained by NCL reaction are 
reduced into the Ala-containing peptides using Raney-Nickel catalyst. Haase et al. [5]  
Figure 1. 
(A) Native chemical ligation. (B) Expanded native chemical ligation. (C) Pseudoproline method.
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reported other modified NCL method for preparation of the Val-containing peptides 
from peptides with one or more penicillamine (β-mercaptovaline) as shown in 
Figure 1B (R1 = R2 = ▬CH3) in a manner similar to Haase et al.
There are synthetic difficult peptides containing specific amino acid sequences. 
Because the difficult sequence-containing peptides and long-chain peptides formed 
β-sheet structure within a molecule, these peptides have high aggregability and low 
solubility in aqueous and organic solvents, and their preparation and purification 
are generally difficult. Although we can use various resin for preparation of difficult 
sequence-containing peptides, such as Tentagel™ (RAPP Polymere, Germany) 
with a PEG moiety on the polystyrene (PS) bead and HDODA resin with a flexible 
crosslinker [6], some game-changing technologies for the preparation of difficult 
sequence-containing peptides has been reported. Mutter et al. reported ‘pseu-
doproline’ method for the preparation of difficult sequence-containing peptides 
and long-chain peptides [7, 8] as shown in Figure 1C. Mutter et al. synthesized 
peptides on a resin using an oxazolidine-containing amino acid (pseudoproline) 
in which α-amino and hydroxyl groups of Ser or Thr are cyclized by acetonidation. 
The deprotection and cleavage of peptides on the resin by a strong acid can convert 
form peptides with cyclic amino acid residue into peptides with Ser or Thr residue. 
Because the cyclic amino acids have a structure similar to Pro and peptides with a 
cyclic amino acid residue have greatly different structure compared with original 
peptides, peptides containing a pseudoproline are prevented to form β-sheet struc-
ture within a molecule. Because the oxazolidine-containing amino acids are labile 
in acid media, the dipeptide units, which consist of Fmoc-protected amino acid and 
oxazolidine-containing amino acid are commercially available.
We previously reported a series of prodrugs based on O-N intramolecular acyl 
migration [9–13]. Furthermore, we reported ‘O-isoacylpeptide’ method for the 
preparation of difficult sequence-containing peptides using the prodrug strategy 
based on O-N intramolecular acyl migration [14, 15].
2. O-N intramolecular acyl migration and prodrugs
Previously, we reported a series of water-soluble prodrugs, such as human immu-
nodeficiency virus type-1 (HIV-1) protease inhibitors and anti-cancer drugs [10–12, 
15]. HIV-1 is a retrovirus that causes the acquired immunodeficiency syndrome 
(AIDS). Since HIV-1 encodes HIV-1 protease that is responsible for the processing of 
viral precursor proteins such as gag and gag-pol polyproteins to form mature struc-
tural proteins and some enzymes required in the production of infective viral par-
ticles, HIV-1 protease is an attractive target for the design of anti-AIDS drugs. HIV-1 
protease is an aspartic protease that consists of a C2-symmetric homodimer, and its 
active site has some hydrophobic pockets. Thus most of the HIV-1 protease inhibi-
tors that are optimized for the active site have high hydrophobicity and are sparingly 
water soluble. Many HIV-1 protease inhibitor formulations contain some solubilizers 
such as polyethylene glycol derivatives that often lead to unwanted side effects in 
clinical use. A water-soluble prodrug of amprenavir, fosamprenavir [16, 17], was 
approved by the US Federal Drug Administration (FDA) in 2003, and amprenavir 
was discontinued by the manufacture in 2004. Our previously reported HIV-1 
protease inhibitors [18–21] also showed poorly water-solubility similar to amprena-
vir. Hence, we designed a series of water-soluble prodrug of HIV-1 protease inhibitor 
using a novel prodrug strategy. An acyl migration on the β-hydroxy-α-amino acid 
residue such as Ser and Thr in strong acids was well-known in peptide chemistry 
[22]. An N-acyl β-hydroxy-α-amino acid residue isomerizes into the O-acyl form 
in strong acids, and O-isoacylpeptide can regenerate the original peptide in weak 
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alkaline media via O-N intramolecular acyl migration (Figure 2A). Since our HIV-1 
protease inhibitors contain a β-hydroxy-α-amino acid residue, (2S,3S)-3-amino-
2-hydroxy-4-phenylbutyric acid (Apns), we designed and synthesized the O-acyl 
isomer of KNI-727 as a water-soluble prodrug. The prodrug of KNI-727 was stable 
as an HCl salt in unbuffered aqueous solutions and in strong acidic solution such 
as gastric juice, and could be rapidly converted to the parent compound, KNI-727, 
via O-N intramolecular acyl migration reaction under the physiological condition 
Figure 2. 
Prodrugs based on O-N intramolecular acyl migration (A) O-N intramolecular acyl migration. (B) Prodrug 
of HIV-1 protease inhibitor, KNI-727. (C) Paclitaxel prodrug. (D) HPLC profile of the O-N intramolecular 
acyl migration of KNI-727 prodrug in PBS (pH 5.5) at 37°C. (E) Time course of the migration reaction of 
KNI-727 prodrug.
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(pH 7.4 PBS, 37°C) as shown in Figure 1B. KNI-727 could be purified by preparative 
HPLC using a reverse-phase C18 column and a linear gradient system of acetonitrile 
and 0.1% TFA. HPLC charts and Time course of the migration reaction in KNI-727 
prodrug were shown in Figure 2D and E respectively. The rate constant and t1/2 were 
calculated using fitting Eq. (1).
 [A]t = AMAX × (1 − Exp(−k × t))(1) (1)
[t, incubation time; k, rate constant of migration; AMAX, maximum concentra-
tion of the parent compound (initial concentration of prodrug); [A], concentration 
of the parent compound].
O-N intramolecular acyl migration of KNI-727 prodrug did not involve any by-
product as shown in Figure 2D and E using the fitting Eq. (1) showed typical first 
order reaction. Hence, this water-soluble prodrug is suitable as an administrated 
drug for the AIDS therapy.
Next, we designed and synthesized water-soluble paclitaxel prodrug [12, 13]. 
Paclitaxel is an anti-cancer agent that was extracted from the Pacific yew tree Taxus 
brevifolia with antineoplastic activity. Since paclitaxel binds to tubulin, it can inhibit 
the disassembly of microtubules, thereby resulting in the inhibition of cell division, 
and also induces apoptosis by binding to the apoptosis inhibitor protein, B-cell leuke-
mia 2 (Bcl-2). As paclitaxel are labile in acidic media such as gastric fluid, the pacli-
taxel formulations had been used as an injectable drug. The paclitaxel is representative 
of poorly water-soluble drug, and its injectable formulations require some detergents, 
such as Cremophor EL, which has been suggested to cause hypersensitivity. By focus-
ing on the β-hydroxy-α-amino acid moiety in the chemical structure of paclitaxel, we 
designed the prodrug, O-benzoyl isopaclitaxel, in which the benzoyl group on the 
amino group of the paclitaxel was moved to its hydroxyl group. This paclitaxel pro-
drug is stable in water as a salt, and can be rapidly converted to the parent drug under 
physiological conditions (t1/2 = 15 min, pH 7.4 PBS, 37°C) as shown in Figure 2C. The 
paclitaxel prodrug seems to be suitable as an injectable drug.
3. O-isoacylpeptide method
Since two natural amino acids, Ser and Thr, have a β-hydroxyl-α-amino acid 
structure, we designed the precursors of biomolecules, so-called ‘O-isoacylpeptides’, 
using our prodrug strategy via O-N intramolecular acyl migration [14–16]. 
O-isoacylpeptides that have an O-acyl ester bond instead of amide bond in the Ser/
Thr residue of biomolecules are promptly converted to the corresponding bio-
molecules under physiological conditions. It is known that some biomolecules are 
aggregate in aqueous solutions because of their β-sheet structure formation. Among 
them, Aβs show strong water-insolubility and aggregability, making their handling 
in biochemical research potentially complicated. Hence, chemical synthesis on resins 
and purification of Aβs, especially Aβ1-42, is particularly challenging. To solve these 
problems, we designed O-isoacyl-Aβ1-42 that has an ester bond instead of the amide 
bond at Gly25-Ser26 in Aβ1-42. Synthesis of Aβ1-42 using O-isoacylpeptide method 
showed in Figure 3A. Peptide bonds formation on the PS-resin was performed by 
9-fluorenylmethoxycarbonyl (Fmoc)-based SPPS using diisopropylcarbodiimide 
(DIPCDI) as a coupling reagent in the present of 1-hydroxybenzotriazole (HOBt). 
The hydroxy group in N-terminal Ser residue of the protected Aβ27-42 that was 
prepared on a resin was esterified by Fmoc-Gly-OH using DIPCDI in the presence 
of catalytic amount of N,N-dimethyl-4-aminopyridine (DMAP). Next, remain-
ing peptide bonds formation using the Fmoc-based SPPS similar to the former 
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procedure formed the protected O-isoacyl-Aβ1-42, and then O-isoacyl-Aβ1-42 was 
obtained by deprotection and cleavage from a resin. O-isoacyl-Aβ1-42 was stable in 
acidic aqueous solution and unbuffered aqueous solution, and could rapidly release 
the native Aβ1-42 peptide. Because O-isoacylisopeptides showed good stability in 
acidic media, O-isoacylisopeptides can be easily isolated and purification in acidic 
solution [23]. In this manner, O-isoacylpeptide method has the advantage over the 
‘pseudoproline’ method. O-isoacyl-Aβ1-42 could be easily synthesized on a resin and 
purified by preparative HPLC using a reverse phase C18 column in acidic eluent 
solvents, and could release native Aβ1-42 that consists of Aβ1-42 monomers. However, 
because ester bond formation on a resin often involves a racemization of protected 
Figure 3. 
O-isoacylpeptide method. (A) Aβ1-42 synthesis via O-N intramolecular acyl migration. (B) Aβ1-42 synthesis 
using an dipeptide unit.
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amino acid, O-isoacyl-dipeptide units such as Boc-Ser(Fmoc-Gly)-OH have been 
commercial available from some chemical suppliers. O-isoacylpeptide method 
using an O-isoacyl-dipeptide unit was shown in Figure 3B. Use of Fmoc-O-isoacyl-
dipeptide allows to synthesize the isoacylpeptides by the conventional Fmoc-based 
SPPS without use of DMAP catalyst.
Furthermore, we designed and synthesized photo cleavable-protected 
O-isoacylpeptide, so called ‘photo-click peptide’. Because O-isoacylpeptides are 
rapidly converted to the biomolecules by stimuli such as pH changes and photo irra-
diation, as with the click of a button, we term ‘click peptide’. Click peptides that can 
Figure 4. 
Photo-click peptide. (A) Synthesis of photo-click Aβ1-42. (B) Photo-click reaction.
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Figure 5. 
Segment condensation of peptides. (A) Conventional segment condensation between peptides. (B) Segment 
condensation using O-isopeptide method.
generate bioactive molecules in situ via a ‘click’ appear to be useful tools for chemi-
cal biology research. Synthesis of photo-click peptide was shown in Figure 4A. 
Photo-click Aβ1-42 could prepare on a resin in a similar manner showed in Figure 3A, 
using photo-cleavable protected amino acid instead of Boc-Ser-OH. Photo-cleavable 
protected amino acid, 6-nitroveratryloxycalbonyl (Nvoc)-Ser-OH, was coupled to 
protected Aβ27-42 on the resin after Fmoc-deprotection, and then Fmoc-Gly-OH was 
coupled on the hydroxyl group of Ser26 using DIPCDI in the presence of catalytic 
amount of DMAP. The remaining peptide bonds formation using the Fmoc-based 
SPPS formed the protected O-isoacyl-Aβ1-42. Deprotection and cleavage from resin 
released O-isoacyl-Aβ1-42. Photo-click Aβ1-42 could rapidly release the native Aβ1-42 
peptide by photo-irradiation and subsequent O-N intramolecular acyl migration 
under physiological condition (Figure 4B).
4. Segment condensation of peptides using O-isoacylpeptides
Although NCL by Kent et al. allowed to preparing the long chain peptides, in 
general, conventional segment condensation other than NCL often involves the 
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racemization of amino acid as shown in Figure 5A. Especially, it is a serious prob-
lem in SPPS because of no purification of intermediates. It is well-known that the 
urethane structure, such as Boc and Fmoc protecting group, on the α-amino group 
of amino acid can prominently reduce the racemization of amino acid in peptide 
bond coupling reaction. Hence, segment condensation between peptides other than 
NCL must not be in peptide chemistry. We noticed the protected O-isoacylpeptide 
structure that possesses a urethane structure on the α-amino group of Ser or 
Thr residue. When an O-isoacylpeptide possessing a urethane-type protecting 
group at the C-terminus was coupled with another peptide, we speculated that 
the condensed peptide may be not racemized at the C-terminal amino acid of 
O-isoacylpeptide. Hence we designed segment condensation method as shown 
in Figure 5B. The segment condensation based on the O-isoacylpeptide method 
showed no racemization [24], and could release the original peptide similar to the 
other O-isoacylpeptides under physiological condition. This method appears to be 
alternative choice to NCL method.
5. Conclusion
Recently, some important synthesis methods such as NCL and pseudoproline 
method for preparation of long chain and difficult sequence-containing peptides 
had been reported. Although these approaches allow to preparing some long chain 
peptides without a genetic engineered approach. However, these methodologies 
are not a panacea for a long chain and difficult sequence-containing peptides. We 
supply alternative solution for the long chain and difficult sequence-containing 
peptide preparation. Namely, we have developed the O-isoacylpeptide method 
for peptide preparation. O-isoacylpeptides that have a/some ester bonds can be 
converted into the parent peptides under physiological condition via the O-N 
intramolecular acyl migration. Moreover, we developed segment condensation with 
no racemization using the O-isoacylpeptide method. The segment condensation 
based on O-isoacylpeptides may be alternative choice to NCL method. We desire to 
apply to these methodologies of various peptide preparations for drug, diagnosis, 
and molecular research.
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